The effect of MGN-3 on cisplatin and doxorubicin induced toxicity in the rat

Journal of Nutraceuticals, Functional and Medical Foods

Volumn 3, Issue 4, 2001, Pages 3-11

  Jacoby, Henry I ^a   Wnorowski, Gary ^a   Sakata, Karl ^a   Maeda, Hiroaki ^a  

^a NONE   (United States)

Author keywords

Chemoprotectants; Chemotherapy; Cisplatin; Doxorubicin; MGN 3; Rats

Indexed keywords

BIOBRAN; CARBOHYDRATE; CISPLATIN; DOXORUBICIN; HEMICELLULOSE; IMMUNOLOGIC AGENT; MGN 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; BODY WEIGHT; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; GASTROINTESTINAL TRACT; LETHALITY; MALE; MOUSE; NONHUMAN; QUALITY OF LIFE; RICE BRAN; STATISTICAL ANALYSIS; WEIGHT GAIN;

ANIMALIA;

EID: 0035711010     PISSN: 10894179     EISSN: None     Source Type: Journal    
DOI: 10.1300/J133v03n04_02     Document Type: Article

References (8)

1. Clinical and preclinical modulation of chemotherapy-induced toxicity in patients with cancer
2. Anti-HIV activity in vitro of MGN-3, an activated arabinoxylane from rice bran
3. Chemoprotectants: A review of their clinical pharmacology and therapeutic efficacy
4. Modulation of platinum-induced toxicities and therapeutic index: Mechanistic insights and first- and second-generation protecting agents
5. Dexrazoxane (ICRF-187)
6. Amifostine: A selective cytoprotective agent of normal tissues from chemo-radiotherapy induced toxicity
7. Amifostine as a protector against cisplatin-induced toxicity in nude mice
8. α from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro